Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2004

View Archived Issues

Synthetic flavonol reduces infarct size and myocardial injury in sheep

Prostaglandin E2 receptor agonist accelerates bone repair in rats

Chloride channel inhibitor prevents bone resorption in ovariectomized rats

Protective effects of vardenafil in the ischemic heart

Enrollment begins in phase II trial of MC-4232

Vicuron reports phase III results for dalbavancin in SSTIs

Sanctura distribution under way

BLA submission for Adacel vaccine

Adderall XR receives FDA approval for use in adults

A.P. Pharma reports initial data for APF-112 and APF-530

Dexanabinol receives orphan drug status

AV-201 cleared to enter phase I/II trial for Parkinson's disease

Spectrum acquires North American, Indian rights to D-631153

Enhance Biotech and Ardent Pharmaceuticals in definitive merger agreement

Topamax approved for migraine prophylaxis

New bradykinin antagonists emerges from Elan R&D

Mexican launch for Sucanon planned

Wyeth and Cambridge Antibody Technology claim new anti-PD-1 antibodies

Guilford plans major PCI trials for Aggrastat

Takeda scientists prepare and evaluate anti-urotensin II antibodies

NeuroSearch and TopoTarget collaborate on Endovion development

New monoamine reuptake inhibitors and their use in pain, emesis and other disorders

BMS researchers design novel serotonin receptor modulators for use as antiobesity agents

Novel factor Xa inhibitors in early development at Boehringer Ingelheim

New PPAR modulators prepared and evaluated by AstraZeneca team

Melanocortin receptor antagonist promising for treatment of obesity and affective disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...